The Impact of Systemic Treatment With Flunixin Meglumine on the Two Antiproteases Alpha‐2‐Macroglobulin ( A2M ) and Alpha‐1‐Antitrypsin ( A1AT ) in Equine Plasma and Platelet‐Rich Fibrin ( PRF )
Veterinary Ophthalmology · 2026-11 · 29 (6)
DOI: 10.1111/vop.70280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Ophthalmology, online erschienen am 16.10.2026. Verfasst von Kaitlyn R Scheunemann und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA. Hauptthemen laut MEDLINE: Clonixin, Anti-Inflammatory Agents, Non-Steroidal, alpha-Macroglobulins. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Purpose
To evaluate the effect of flunixin meglumine, a systemic non‐steroidal anti‐inflammatory drug (NSAID), on the antiproteases, A2M and A1AT, in equine plasma and PRF.
Methods
A prospective cross‐sectional study. Plasma, solid PRF, and liquid PRF were collected from a control‐group that included healthy horses not treated with NSAIDs within the last 3 months. The NSAID‐group were ophthalmology patients with no systemic inflammatory disease, and all received a full dose of flunixin meglumine (1.1 mg/kg BID PO or IV) for three or more days prior to collection. Samples were collected and prepared using a standardized protocol for plasma and PRF preparation. Concentrations of A2M and A1AT were analyzed with ELISA kits. Statistical analysis with Mann–Whitney U tests and Wilcoxon signed‐rank tests was performed using significance set at p < 0.05.
Results
No significant differences were found between the control‐group ( n = 12) and NSAID‐group ( n = 12) for any of the blood products ( p > 0.05). Plasma had a significantly higher amount of A2M compared to solid and liquid PRF (both p < 0.001). Solid PRF had the highest concentration of A1AT and was significantly higher when compared to liquid PRF ( p < 0.001), but not when compared to plasma ( p = 0.071).
Conclusions
The systemic NSAID, flunixin meglumine, does not appear to significantly alter antiprotease concentrations in equine plasma or PRF. Although PRF should not be used as a replacement for plasma, solid PRF may be a good adjunctive therapy for the treatment of keratomalacia due to its high A1AT concentration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Science, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.
- Biobehavioral Laboratory, School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- KR Love Quantitative Consulting and Collaboration, Athens, Georgia, USA.
ORCID-Profile: Kaitlyn R Scheunemann, Katrina E V Jones, Kimberly Young, Cody McGrath, Kimberly R Love, Michala de Linde Henriksen
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Scheunemann, K. R., Jones, K. E. V., Young, K., Zhang, C., McGrath, C., Love, K. R., & de Linde Henriksen, M. (2026). The Impact of Systemic Treatment With Flunixin Meglumine on the Two Antiproteases Alpha‐2‐Macroglobulin ( A2M ) and Alpha‐1‐Antitrypsin ( A1AT ) in Equine Plasma and Platelet‐Rich Fibrin ( PRF ). Veterinary Ophthalmology, 29(6). https://doi.org/10.1111/vop.70280
Vancouver
Scheunemann KR, Jones KEV, Young K, Zhang C, McGrath C, Love KR, et al. The Impact of Systemic Treatment With Flunixin Meglumine on the Two Antiproteases Alpha‐2‐Macroglobulin ( A2M ) and Alpha‐1‐Antitrypsin ( A1AT ) in Equine Plasma and Platelet‐Rich Fibrin ( PRF ). Veterinary Ophthalmology. 2026;29(6). doi:10.1111/vop.70280
BibTeX
@article{Scheunemann2026,
author = {Scheunemann, Kaitlyn R and Jones, Katrina E V and Young, Kimberly and Zhang, Chongben and McGrath, Cody and Love, Kimberly R and de Linde Henriksen, Michala},
title = {The Impact of Systemic Treatment With Flunixin Meglumine on the Two Antiproteases Alpha‐2‐Macroglobulin ( A2M ) and Alpha‐1‐Antitrypsin ( A1AT ) in Equine Plasma and Platelet‐Rich Fibrin ( PRF )},
journal = {Veterinary Ophthalmology},
year = {2026},
volume = {29},
number = {6},
doi = {10.1111/vop.70280}
}
EUVIMED